TEE
GLSI icon

Tibra Equities Europe’s Greenwich LifeSciences GLSI Stock Holding History

Tibra Equities Europe’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-12,700
Closed -$496K – 27
2021
Q3 		$496K Buy
+12,700
New +$531K 0.76% 16

Other funds holding GLSI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Tibra Equities Europe's GLSI Position: Q4 2021 in Review

Tibra Equities Europe sold out of Greenwich LifeSciences (GLSI) in Q4 2021, closing a stake of 12,700 shares — an estimated $496K sold.

Tibra Equities Europe first reported a position in GLSI in Q3 2021 and held it in 1 quarter. The position peaked at $496K in Q3 2021. 35 funds tracked by Wall St. Rank hold GLSI as of Q4 2021.

  • Tibra Equities Europe reported no remaining Greenwich LifeSciences position as of Q4 2021 after selling out during the quarter.
  • Tibra Equities Europe sold 12,700 Greenwich LifeSciences shares in Q4 2021, an estimated $496K.
  • Tibra Equities Europe first reported a position in Greenwich LifeSciences in Q3 2021 and held it in 1 quarter.
  • Tibra Equities Europe's Greenwich LifeSciences position peaked at $496K in Q3 2021.
  • 35 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q4 2021.

Based on Tibra Equities Europe's 13F filing for Q4 2021, filed 14 Feb 2022.